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Chaperone-mediated autophagy (CMA) governs degradation of cytosolic proteins damaged by nutritional
changes and declines with age. In this issue, Schneider et al. (2014) reveal CMA as a novel player in the
regulation of liver lipid and carbohydrate metabolism and suggest that defects in CMA may play a major
role in metabolic dysregulation.A common trait of life is an ability to adapt
metabolism to available nutrients and
physiological changes. Autophagy has
been conserved during evolution to
recycle nutrients from intracellular com-
ponents for metabolic use (Boya et al.,
2013). The best characterized form of
autophagy, known as macroautophagy,
sequesters cytoplasmic material to
deliver cargo into the lysosomal com-
partment for degradation and promote
recycling of fatty acids and amino acids.
Macroautophagy participates in meta-
bolic regulation in normal cells and plays
a crucial role in maintenance of the
nutrient supply to cancer cells (Rabino-
witz and White, 2010; White, 2013).
In this issue of Cell Metabolism,
Schneider et al. (2014) demonstrate a
novel role for the chaperone-mediated
autophagy (CMA) pathway in the regula-
tion of liver lipid and carbohydrate meta-
bolism. CMA is an alternative form of
autophagy used by mammalian cells to
import the 30% of cytosolic proteins that
contain a KFERQ-based motif into the
lysosome (Cuervo and Wong, 2014).
CMA substrates are selectively recog-
nized by the chaperone 70 kDa heat
shock cognate protein (HSC70) in the
cytosol and translocated to the lysosomal
lumen for degradation by a complex
formed by multimerization of the lyso-
somal membrane protein, LAMP2A.
Nutritional variations affect both CMA
and macroautophagy, and both pro-
cesses decline with age in most tissues.
CMA contributes to protein degradation
and amino acid recycling after prolonged
starvation, whereas macroautophagy is
stimulated shortly after nutritional chal-
lenges and declines following prolonged392 Cell Metabolism 20, September 2, 2014 ªstarvation (Cuervo and Wong, 2014).
CMA is also upregulated by oxidative
stress and contributes to cellular quality
control by removing damaged proteins
(Cuervo and Wong, 2014).
To study the functional role of CMA in
liver homeostasis, Schneider et al. gener-
ated mice with a liver-specific conditional
knockout of Lamp2A, the only spliced
variant of the Lamp2 gene that partici-
pates in CMA (Cuervo and Wong, 2014).
While these mice displayed liver-specific
failure in CMA, liver macroautophagy
was unaffected. CMA-deficient mice
spontaneously developed massive stea-
tosis, a phenotype further accentuated
upon starvation or overfeeding. More-
over, blood glucose homeostasis was
altered and hepatic glycogen content
depleted as a consequence of a
shift from carbohydrate synthesis and
storage toward carbohydrate utilization
and enhanced glycolysis. Furthermore,
dysregulation of carbohydrate and lipid
metabolism resulting from hepatic CMA
failure negatively impacted whole-body
energy homeostasis upon nutritional
challenges (starvation and overfeeding),
with increased energy expenditure and
reduced peripheral fat mass.
Possibly explaining these metabolic
changes, a comparative analysis of pro-
teins undergoing CMA-dependent and
CMA-independent degradation revealed
that key enzymes of carbohydrate meta-
bolism, including glycolytic enzymes
and TCA-related enzymes, are substrates
for CMA. Interestingly, 30% of the pro-
teins identified as CMA substrates also
participate in lipid metabolism, mainly in
triglyceride synthesis. Indeed, CMA defi-
ciency caused a reduction in lysosomal2014 Elsevier Inc.degradation of lipid metabolism enzymes,
in particular lipogenic enzymes such
as glycerol-3-phosphate dehydrogenase,
with concurrent accumulation of these
proteins in the cytosol. In addition, CMA-
deficient hepatocytes had reduced mito-
chondrial fatty acid oxidation, probably
resulting from a higher routing of free fatty
acids toward lipogenesis rather than from
a defect in mitochondrial morphology or
changes in macroautophagy-dependent
degradation (mitophagy). Finally, en-
hanced lipogenesis, decreased b-oxida-
tion, and reduced secretion of very-low-
density lipoproteins were also observed
in the livers of CMA-deficient animals.
These data demonstrate that CMA is
a major protective pathway against
steatosis via combined inhibitory effects
on de novo biosynthesis of fatty acids
(lipogenesis) and indirect beneficial im-
pacts on b-oxidation and enhanced fat
export (Figure 1). Interestingly, CMA may
also limit liver injury, since CMA-deficient
mice show enhanced transaminase
serum levels and increased hepatocyte
apoptosis, a phenotype more pro-
nounced in overfed animals.
The role of bulk macrophagy and
selective macroautophagy (lipophagy) in
the regulation of hepatic metabolism has
been extensively described (Codogno
and Meijer, 2013; Schneider and Cuervo,
2014). The work of Schneider et al.
(2014) now sheds light on a novel function
for CMA and suggests that defects in
CMA may be of major importance in
metabolic dysregulation. Interestingly,
the phenotype of CMA-deficient mice
recapitulates some of the metabolic
changes observed during aging, including
energetic deficiencies and the inability to
Figure 1. Chaperone-Mediated Autophagy and Macroautophagy in the Regulation of Liver
Metabolism
Degradation along the macroautophagic pathway fuels cells during starvation with free fatty acids (FFA)
and amino acids (AA) via the induction of lipophagy (selective macroautophagy for lipid droplets) (filled
red circle) and bulk macroautophagy. The fusion of autophagosomes with the lysosomal compartment
is dependent on LAMP2B. Novel findings by Schneider et al. (2014) show that starvation-stimulated
CMA contributes to liver metabolism. CMA controls the levels of KFERQ-motif-containing glycolytic,
lipid metabolism, and TCA (tricarboxylic acid) cycle enzymes that are degraded through HSC70- and
LAMP2A-dependent pathways.
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also raises several important questions.
In particular, whether this CMA-depen-
dent regulation of cell metabolism ex-
tends beyond liver cells remains to be
investigated, but this is likely the case
since CMA is present in most tissues
(Cuervo and Wong, 2014). In addition,
Schneider et al.’s findings lead to the
quest of how CMA disruption in the liver
may impact peripheral tissues. Ketone
bodies, which are potent stimulators of
CMA, are potential candidates, since
they are produced in the liver and can be
used by other tissues upon metabolic
demand (Finn and Dice, 2006). Moreover,
since the presence of HSC70 in lysosomal
lumen is crucial for sensitizing this organ-elle to CMA (Cuervo and Wong, 2014), it
will also be of interest to assess whether
the proportion of CMA-competent versus
CMA-incompetent lysosomes varies as
a function of metabolic status. More
generally, variations in the activity of the
CMA translocation machinery upon
metabolic changes remain to be exam-
ined in detail. In particular, whether
variations in LAMP2A and HSC70 levels
could be affected by nutritional changes
and compensate for a reduction of CMA
would need to be investigated (Cuervo
and Wong, 2014).
Finally, a key future direction that
emerges from this work is whether
CMA dysregulation underlies chronic liver
injury. Alcoholic and nonalcoholic fattyCell Metabolism 20, Sliver disease have common pathological
features ranging from steatosis to steato-
hepatitis (steatosis associated with
hepatocyte death and inflammation) with
a 20% risk for cirrhosis after 20 years,
following activation of fibrogenesis (Marra
and Lotersztajn, 2013). Obviously, the
novel finding that CMA limits excessive
cellular lipid accumulation and protects
against liver injury suggests that CMA
may regulate different steps of alcoholic
and nonalcoholic fatty liver disease pro-
gression. The recent discovery that the
inhibitory effect of retinoic acid receptor
alpha on CMA is neutralized by deriva-
tives of all-trans retinoic acid (Anguiano
et al., 2013) paves the way for the devel-
opment of CMAmodulators to circumvent
metabolic dysregulation in pathological
situations. However, as both macro-
autophagy and CMA are central in the
regulation of metabolism, a better under-
standing of how these two processes
are coordinated will be critical before
CMA and macroautophagy modulators
are targeted for therapeutic development.REFERENCES
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